Weight Loss Drug Belviq Found To Increase Cancer Risk
MSN,
The agency approved the sale of lorcaserin to help people manage weight-related medical issues or obesity.
The agency approved the sale of lorcaserin to help people manage weight-related medical issues or obesity.
A large study shows that the popular weight loss drug lorcaserin, also known as Belviq, could put people at risk of cancer.
The company that makes the weight loss drug Belviq is pulling it from the market at the request of federal regulators, who…
Results from a clinical trial assessing the safety of Belviq and Belviq XR (lorcaserin) show the drug may be associated with an…